相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study
M. Sinn et al.
ANNALS OF ONCOLOGY (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer
Hiroaki Kasashima et al.
CANCER LETTERS (2014)
The stromal compartments in pancreatic cancer: Are there any therapeutic targets?
Serena Lunardi et al.
CANCER LETTERS (2014)
Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells
Jian Guan et al.
CANCER LETTERS (2014)
SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target
Jianguo Feng et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Retraction Note to: IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
X Sun et al.
ONCOGENE (2014)
CXCL12 Chemokine Expression Suppresses Human Pancreatic Cancer Growth and Metastasis
Ishan Roy et al.
PLOS ONE (2014)
The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma
Khalid A. Jazieh et al.
SEMINARS IN RADIATION ONCOLOGY (2014)
Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies
Agnieszka Anna Rucki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
CXCL12-CXCR4 Promotes Proliferation and Invasion of Pancreatic Cancer Cells
Bo Shen et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Stromal expression of SPARC in pancreatic adenocarcinoma
Cindy Neuzillet et al.
CANCER AND METASTASIS REVIEWS (2013)
Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma
Abasi Ene-Obong et al.
GASTROENTEROLOGY (2013)
SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines
Feng Pan et al.
MOLECULAR BIOLOGY REPORTS (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Exogenous SPARC Suppresses Proliferation and Migration of Prostate Cancer by Interacting With Integrin β1
Minkyoung Shin et al.
PROSTATE (2013)
Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells
Shin Hamada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Fibroblast activation protein A potential therapeutic target in cancer
Rui Liu et al.
CANCER BIOLOGY & THERAPY (2012)
Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells
Wen-Shih Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance
Min Shi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells
Hyung-Ok Lee et al.
BMC CANCER (2011)
Retinoic Acid-Induced Pancreatic Stellate Cell Quiescence Reduces Paracrine Wnt-β-Catenin Signaling to Slow Tumor Progression
Fieke E. M. Froeling et al.
GASTROENTEROLOGY (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
SPARC Promotes Cathepsin B-Mediated Melanoma Invasiveness through a Collagen I/α2β1 Integrin Axis
Maria R. Girotti et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells
Kazuhiro Kikuta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
S. Singh et al.
BRITISH JOURNAL OF CANCER (2010)
Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation Implications for breast cancer and DCIS therapy with autophagy inhibitors
Ubaldo E. Martinez-Outschoorn et al.
CELL CYCLE (2010)
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma
Shanna A. Arnold et al.
DISEASE MODELS & MECHANISMS (2010)
Stromal Depletion Goes on Trial in Pancreatic Cancer
Ken Garber
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α
Matthew Kraman et al.
SCIENCE (2010)
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
R. Marechal et al.
BRITISH JOURNAL OF CANCER (2009)
Galectin-1 Is a Novel Functional Receptor for Tissue Plasminogen Activator in Pancreatic Cancer
Oriol Roda et al.
GASTROENTEROLOGY (2009)
CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer
Yoichi Matsuo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Chmp 1A is a mediator of the anti-proliferative effects of All-trans Retinoic Acid in human pancreatic cancer cells
Jing Li et al.
MOLECULAR CANCER (2009)
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin
Aaron M. LeBeau et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts
Elinborg Ostermann et al.
CLINICAL CANCER RESEARCH (2008)
Forced expression of MMP9 rescues the, loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC
Shanna Arnold et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
Steven J. Cohen et al.
PANCREAS (2008)
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts
Elisabeth M. Zeisberg et al.
CANCER RESEARCH (2007)
Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma
Jeffrey R. Infante et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner
B Guleng et al.
CANCER RESEARCH (2005)
CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells
TN Hartmann et al.
ONCOGENE (2005)
Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction
G Ishii et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression
K Yamashita et al.
CANCER (2003)
分享论文
